v3.26.1
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

 

   2026   2025   2026   2025 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2026   2025   2026   2025 
                 
Research and development  $36,015   $31,016   $51,777   $66,989 
General and administrative   22,130    34,189    71,766    69,218 
                     
Total  $58,145   $65,205   $123,543   $136,207 
Schedule of Key Assumption of Fair Value of Stock Options Granted

For options granted during the six months ended June 30, 2026 and 2025, the Company calculated the fair value of each option grant on the respective dates of grant using the following weighted average assumptions:

 

   2026   2025 
Expected term   5.83 years   5.73 years
Risk-free interest rate   4.04%   4.30%
Expected dividend yield        
Expected volatility   90.87%   94.19%
Schedule of Stock Option Activity

A summary of stock option activity is as follows:

 

   Outstanding stock options 
   Number of shares   Weighted average exercise price 
Balance at December 31, 2024   335,258   $23.59 
Options granted   100,994    4.22 
Options exercised   -    - 
Options forfeited   (8,327)   4.62 
Options cancelled   (10,616)   48.83 
Balance at December 31, 2025   417,309    18.64 
Options granted   97,073    4.66 
Options exercised   (1,325)   5.27 
Options forfeited   (22,053)   116.04 
Options cancelled   (5,966)   3.66 
Balance at June 30, 2026   485,038    11.64 
           
Options exercisable at June 30, 2026   279,159    16.89 
Schedule of Share-based Compensation of Stock Options Outstanding and Exercisable

The following table summarizes information about stock options outstanding and exercisable:

 

As of June 30, 2026
Options outstanding  Options exercisable 
Number outstanding  Weighted average remaining contractual life (Years)   Weighted average exercise price   Aggregate intrinsic value   Number exercisable   Weighted average remaining contractual life (Years)   Weighted average exercise price   Aggregate intrinsic value 
                                    
485,038   7.01   $11.64   $1,588    279,159    5.20   $16.89   $- 

 

As of June 30, 2025
Options outstanding  Options exercisable
Number outstanding  Weighted average remaining contractual life (Years)   Weighted average exercise price   Aggregate intrinsic value   Number exercisable  Weighted average remaining contractual life (Years)   Weighted average exercise price   Aggregate intrinsic value 
                                  
354,908   6.60   $21.26   $-   256,738   5.59   $27.57   $- 
Summary of Restricted Stock Unit Activity

A summary of restricted stock unit activity is as follows:

 

   Number of Unvested Restricted Stock Units 
     
Balance at December 31, 2025   18,137 
Granted   - 
Vested   (1,209)
Cancelled   - 
Balance at June 30, 2026   16,928